摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-dibromo-6,7-dihydro-1H-pyrrolo<2,3-c>azepin-8-one | 154468-45-8

中文名称
——
中文别名
——
英文名称
2,3-dibromo-6,7-dihydro-1H-pyrrolo<2,3-c>azepin-8-one
英文别名
2,3-dibromo-1H-pyrrolo[2,3-c]pyridin-7(6H)-one;MCG980;2,3-Dibromo-6,7-dihydro-1H-pyrrolo[2,3-c]azepin-8-one;2,3-Dibromo-6,7-dihydropyrrolo[2,3-c]azepin-8(1H)-one
2,3-dibromo-6,7-dihydro-1H-pyrrolo<2,3-c>azepin-8-one化学式
CAS
154468-45-8
化学式
C8H6Br2N2O
mdl
——
分子量
305.956
InChiKey
OHTUDDNYUHUIAU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    44.9
  • 氢给体数:
    2
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,3-dibromo-6,7-dihydro-1H-pyrrolo<2,3-c>azepin-8-one 在 palladium on activated charcoal 氢气sodium acetate溶剂黄146三氟乙酸 作用下, 以 甲醇氘代二甲亚砜 为溶剂, 反应 147.0h, 生成 (Z)-isoaxinohydantoin
    参考文献:
    名称:
    Synthesis of Axinohydantoins
    摘要:
    A short synthesis of the hydantoin-containing marine sponge metabolites axinohydantoins is described. A key feature of the synthesis is a putative biomimetic, intramolecular cyclization of alpha-functionalized imidazolone 5, which affords the tricyclic pyrroloazepinone framework comprising 6. In addition, the conversion of imidazolones to alpha,beta-unsaturated hydantoins is outlined and represents a new approach to these heterocyclic systems.
    DOI:
    10.1021/jo020063v
  • 作为产物:
    描述:
    2-(三氯乙酰)吡咯甲烷磺酸溶剂黄146 作用下, 以 乙腈 为溶剂, 反应 212.0h, 生成 2,3-dibromo-6,7-dihydro-1H-pyrrolo<2,3-c>azepin-8-one
    参考文献:
    名称:
    Latonduines A和B,从海洋海绵Stylissa carteri分离得到的新生物碱:结构阐明,合成和生物遗传学意义。
    摘要:
    [结构:见正文] Latonduines A(6)和B(7)是两种新的具有前所未有的杂环骨架的生物碱,已从印度尼西亚海洋海绵Stylissa carteri中分离出来。通过分析光谱数据阐明了latonduines的结构,并通过latonduine A的全合成对其进行了证实(6)。提出鸟氨酸是拉托二胺的氨基嘧啶片段的生物遗传前体。
    DOI:
    10.1021/ol034950b
点击查看最新优质反应信息

文献信息

  • Synthesis of the marine carbinolamine (+/−) longamide control of N-1 and C-3 bromopyrrole nucleophilicity
    作者:S. Marchais、A. Al Mourabit、A. Ahond、C. Poupat、P. Potier
    DOI:10.1016/s0040-4039(99)01092-8
    日期:1999.7
    examined. The ring-chain tautomerism involving a potential nucleophilicity of N1/C3 of bromopyrrole compounds has been examined. The behaviour of 7 in protic mild or in vigorous acidic conditions provides an entry to regioselective synthesis of marine polycycle alkaloids such as 2, 3, and 4. A biogenetic pathway is proposed for polycyclic 2-aminoimidazolopyrrole marine metabolites.
    描述了使用可能的仿生环化12的(+/-)长酰胺1的短合成。研究了其对映体形式的分离及其外消旋化。已经研究了涉及溴吡咯化合物的N 1 / C 3潜在亲核性的环链互变异构。7在质子性轻度或强烈酸性条件下的行为为海洋多环生物碱(如2、3和4)的区域选择性合成提供了一个入口。提出了多环2-氨基咪唑并吡咯海洋代谢物的生物遗传途径。
  • Intermediates for the synthesis of debromohymenialdisine and processes thereof
    申请人:The Trustees of Columbia University in the City of New York
    公开号:US06197954B1
    公开(公告)日:2001-03-06
    The synthesis of C11N5 marine sponge alkaloids (±)-hymenin (1), stevensine (2), hymenialdisine (3), and debromohymenialdisine (4) is described. These natural products are the primary family members of the sponge metabolites that contain a fused pyrrolo[2,3-c]azepin-8-one ring system with either a 2-aminoimidazole (AI) or glycocyamidine appendage. The key steps in the synthesis centered around the generation of novel azafulvenium ions and their regioselective heterodimerization with AI in order to create the tricyclic core. A rarely used protodebromination/oxidation strategy was employed to selectively generate the desired a-bromo substitution pattern seen in hymenialdisine (3). In addition, the AI moiety was shown to be a useful precursor to the glycocyamidine unit found in 3 and 4, which suggests that AI derived natural products may be the biogenic forerunners to glycocyamidine metabolites.
    本文描述了C11N5海绵生物碱(±)-hymenin(1)、stevensine(2)、hymenialdisine(3)和debromohymenialdisine(4)的合成。这些天然产物是含有融合的吡咯[2,3-c]氮杂环-8-酮环系和2-氨基咪唑(AI)或甘氨酰胺补集的海绵代谢物的主要成员。合成的关键步骤围绕着产生新型氮杂富烯离子及其与AI的选择性异二聚化以创建三环核心。采用很少使用的质子去溴/氧化策略选择性地产生了hymenialdisine(3)中所见的所需的a-溴代替模式。此外,AI基团被证明是3和4中发现的甘氨酰胺单元的有用前体,这表明以AI为来源的天然产物可能是甘氨酰胺代谢物的生物前体。
  • A synthesis of (±)-hymenin
    作者:Ying-zi Xu、Giao Phan、Kenichi Yakushijin、David A. Horne
    DOI:10.1016/0040-4039(94)85051-8
    日期:1994.1
    (±)-Hymenin (1) has been synthesized by a highly efficient route involving the generation of an azafulvene intermediate and its coupling with 2-aminoimidazole.
    (±)-处女膜素(1)已经通过涉及氮杂富烯中间体的产生及其与2-氨基咪唑的偶联的高效途径合成。
  • Synthesis of C<sub>11</sub>N<sub>5</sub> Marine Sponge Alkaloids:  (±)-Hymenin, Stevensine, Hymenialdisine, and Debromohymenialdisine
    作者:Ying-zi Xu、Kenichi Yakushijin、David A. Horne
    DOI:10.1021/jo9619746
    日期:1997.2.1
    The synthesis of C(11)N(5) marine sponge alkaloids (+/-)-hymenin (1), stevensine (2), hymenialdisine (3), and debromohymenialdisine (4) is described. These natural products are the primary family members of the sponge metabolites that contain a fused pyrrolo[2,3-c]azepin-8-one ring system with either a 2-aminoimidazole (AI) or glycocyamidine appendage. The key steps in the synthesis centered around
    描述了C(11)N(5)海洋海绵生物碱(+/-)-膜虫素(1),stevensine(2),膜虫碱(3)和debromohymenialdisine(4)的合成。这些天然产物是海绵代谢物的主要家族成员,其包含带有2-氨基咪唑(AI)或糖嘧啶附肢的稠合吡咯并[2,3-c] azepin-8-环系统。合成中的关键步骤集中在新型氮杂富烯鎓离子的产生及其与AI的区域选择性异二聚化反应上,以产生三环核。很少使用的原去溴化/氧化策略被用来选择性地产生在膜虫碱中看到的所需的α-溴取代模式(3)。此外,显示AI部分是3和4中发现的糖嘧啶单元的有用前体。
  • Intermediates for the synthesis of debromohymenialdisine and process thereof
    申请人:The Trustees of Columbia University in the City of New York
    公开号:US20010012891A1
    公开(公告)日:2001-08-09
    The synthesis of C 11 N 5 marine sponge alkaloids (±)-hymenin (1), stevensine (2), hymenialdisine (3), and debromohymenialdisine (4) is described. These natural products are the primary family members of the sponge metabolites that contain a fused pyrrolo[2,3-c]lazepin-8-one ring system with either a 2-aminoimidazole (AI) or glycocyamidine appendage. The key steps in the synthesis centered around the generation of novel azafulvenium ions and their regioselective heterodimerization with AI in order to create the tricyclic core. A rarely used protodebromination/oxidation strategy was employed to selectively generate the desired a-bromo substitution pattern seen in hymenialdisine (3). In addition, the AI moiety was shown to be a useful precursor to the glycocyamidine unit found in 3 and 4, which suggests that AI derived natural products may be the biogenic forerunners to glycocyamidine metabolites.
    本文描述了C11N5海绵生物碱(±)-hymenin (1)、stevensine (2)、hymenialdisine (3)和debromohymenialdisine (4)的合成。这些天然产物是含有融合的吡咯[2,3-c]噻唑啉-8-酮环系统的海绵代谢产物家族的主要成员,其附有2-氨基咪唑(AI)或甘氨酰胺补集。合成的关键步骤集中在产生新型氮杂富烯离子及其与AI的选择性杂二聚化,以创建三环核心。采用了很少使用的质子去溴/氧化策略,以有选择性地产生hymenialdisine (3)中所见的所需α-溴取代模式。此外,AI基团被证明是3和4中发现的甘氨酰胺单位的有用前体,这表明AI衍生的天然产物可能是甘氨酰胺代谢产物的生物前体。
查看更多

同类化合物

环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 吡咯并[1,2-a]氮杂-5-酮 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 (1R*,2E,11S*)-2-(cyclohexylmethylene)-1-(phenylsilyl)methyloctahydropyrrolo[1,2-a]azepine (R)-2-(6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]azepin-9-yl)-acetaldehyde curvulamine (3aR,8aS)-tert-butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride tert-butyl 6-(2-amino-2-oxoethyl)-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate 3-benzoyl-10-bromo-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-(tert-butyloxycarbonyl)-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethylazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethyl-6-methylazepino[4,5-b]indole (Z)-2,3,9,9a-tetrahydro-6,6-dimethyl-9-methylene-8-vinyl-1H-pyrrolo[1,2-a]azepin-5(6H)-one 2,3,4,5,6,7-hexahydro-1H-3a,8,13,13b-tetraazabenzo[b]cyclopenta[1,2,3-jk]fluorene 2,3,4,5,6,7-hexahydro-1H-3a,8,11,11b-tetraazacyclohepta[1,2,3-jk]fluorene 1-Benzyloxy-2-methoxy-7,8,9,10-tetrahydro-6H-azepino<1,2-a>indole-11-carbaldehyde 3-benzoyl-10-(2-propoxyphenyl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 2-phenyl-2,4,5,6-tetrahydro-1H-6-azabenzo[a]cyclohepta[cd]azulen-1-one 2-carbetoxy-3-(N,N-dimethyl)aminomethyleneamino-8-oxo-8H-4,5,6,7-tetrahydropyrrolo<2,3-c>azepine 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-benzoyl-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 6-[2-(4-fluorophenyl)ethyl]-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 5-(2-hydroxy-3-morpholin-4-yl-propyl)-3-methyl-4-oxo-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde 6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 11-(tert-butyldimethylsilyloxy)-1-trimethylsilyl-3a,4,11,12-tetrahydro-3H-cyclopenta[5,6]azepine[1,2-a]indole-2-one tert-butyl 8,9-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl 9,10-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl (1R,4S)-1-(benzylcarbamoyl)-3-oxo-2-((S)-1-phenylethyl)-1,2,3,4,5,10-hexahydroazepino[3,4-b]indol-4-ylcarbamate